Activated macrophages play an important role in many inflammatory diseases. However, the molecular mechanisms controlling macrophage activation are not completely understood. Here we report that a novel CCCH zinc finger protein family MCPIP1, 2, 3 and 4, encoded by four genes Zc3h12a, Zc3h12b, Zc3h12c and Zc3h12d respectively, regulates macrophage activation. Northern blot analysis revealed that the expression of MCPIP1 and MCPIP3 were highly induced in macrophages in response to treatment with lipopolysaccharide (LPS). Although not affect cell surface marker expression and phagocytotic function, overexpression of MCPIP1 significantly blunted LPS-induced inflammatory cytokine and NO 2 -production as well as their gene expression. Conversely, short interfering RNA-mediated reduction in MCPIP1 augmented LPS-induced inflammatory gene expression. Further studies demonstrated that MCPIP1 did not directly affect the mRNA stability of tumor necrosis factor α (TNFα) and monocyte chemoattractant protein 1 (MCP-1), but strongly inhibited LPS-induced TNFα and inducible nitric oxide synthase (iNOS) promoter activation. Moreover, we found that forced expression of MCPIP1 significantly inhibited LPS-induced nuclear factor (NF)-κB activation. These results identify MCPIPs, a novel CCCH zinc finger protein family, as negative regulators in macrophage activation and may implicate in host immunity and inflammatory diseases.
cytokines, growth factors, and proteolytic enzymes that are critical for tissue damage and repair (1) . Numerous extracellular inducers of macrophage activation have been identified, among of which the most studied are LPS and interferon γ (IFNγ) (2) . LPS is a structurally heterogenous material contained within the cell wall of gram-negative bacteria and is recognized by animals as a molecule correlating to infection. It binds to Toll-like receptor 4 (TLR4), triggering multiple signaling cascades including those mediated through the transcription factor NF-κB and the Janus N-terminal kinase and p38 kinase pathways (3) .
Much attention has focused on the proinflammatory signaling in activated macrophages but little is known about the mechanisms that negatively control inflammation. Understanding the molecular mechanisms involved in the inflammatory processes in macrophages is essential to the development of novel drug therapies against inflammatory diseases including atherosclerosis.
Previously, we identified a novel CCCH-zinc finger containing protein, which was significantly induced by MCP-1 in human peripheral blood monocytes and thus designated as MCP-induced protein (MCPIP) (4) . By searching the similar sequences in Genbank (www.ncbi.nlm.nih.gov), we here found that four members belong to this protein family designated as MCPIP1, 2, 3 and 4 and encoded by four genes Zc3h12a, Zc3h12b, Zc3h12c and Zc3h12d respectively. The obvious feature of this protein family is that they all contain a single CCCHtype zinc finger and their function remains unknown.
Zinc finger proteins comprise a large superfamily. It is estimated that there are 1% of all mammalian genes encoded zinc fingers. There are at least 14 different types of fingers, categorized by the nature and spacing of their zinc-chelating residues.
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Most of zinc fingers are CCHH-or CCCC-type (referred to as classical zinc fingers). CCCH-type zinc finger containing proteins are very unusual in mammalian genomes and represent approximately 0.8% of all zinc finger containing proteins (5, 6) . A well-studied CCCH-zinc finger protein family is tristetraprolin (TTP, also known as Zfp36) family, which also contains four members TTP, Zfp36l1, Zfp36l2 and Zfp36l3. This protein family contains two tandem CCCH-zinc fingers and binds to AU-rich elements in mRNA, leading to the removal of the poly(A) tail from that mRNA and increased rates of mRNA turnover (7) (8) (9) . ZAP, which is also a CCCHtype zinc finger protein, can bind to viral RNA to cause profound and specific loss of viral mRNA (10) . Roquin, another CCCH-zinc finger protein, functions as an ubiquitin ligase and is required to repress autoimmunity (11) .
In this study, we found that the members of MCPIP family were dramatically induced by LPS in macrophages.
Overexpression of MCPIP1 significantly attenuated LPS-induced inflammatory cytokine and NO 2 -production and their gene expression perhaps by antagonizing NF-κB signaling. These results indicate that they may be novel regulators in macrophage activation.
MATERIALS AND METHODS
Mice-Male C57BL/6 wild-type mice (~6-8 wk old) were purchased from The Jackson Laboratories (Bar Harbor, ME) and housed in a temperature-controlled environment with 12 hr light/dark cycles at University of Central Florida Transgenic Animal Facility in accordance with the principles of Animal Care of National Institutes of Health. These studies were reviewed and approved by the Institutional Animal Care and Use Committee of University of Central Florida.
Cells-The mouse macrophage cell line RAW264.7 was obtained from American Type Culture Collection (ATCC) and maintained in RPMI 1640 supplemented with 2 mM glutamine, 100 U/ml of penicillin and streptomycin, and 10% Fetal Bovine Serum (FBS) (Sigma, endotoxin<1ng/ml). The human acute monocytic leukemia cell line THP-1 was obtained from ATCC and maintained in RPMI 1640 medium with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES and 1.0 mM sodium pyruvate and supplemented with 0.05 mM 2-mercaptoethanol, 10% FBS. THP-1 cells were stimulated with 100 nM/L phorbol 12-myristate 13-acetate (PMA) for 5 days to differentiate into macrophages and then quiescent for 16-24 hours by cultured in macrophage serum-free medium (Invitrogen).
Mouse bone marrow-derived macrophages (BMDM) were generated from bone marrow stem cells obtained from femurs of the male C57BL/6 mice (2-4 month old). After lysis of the red blood cells, 4×10 6 of bone marrow stem cells were inoculated in 6-well plate with complete Dulbecco's modified Eagle's medium (DMEM) culture medium containing 10% FBS, 30% L-medium, and standard supplements. After 7-d culture, the fully differentiated and matured BMDM were quiescent for 24 hours in macrophage serum-free medium and then treated with 1 μg/ml LPS for different time points.
HEK293 cells were cultured in DMEM supplemented with 2 mM glutamine, 100 U/ml of penicillin and streptomycin, and 10% FBS.
Plasmids-Human MCPIP1 expression plasmid (pMCPIP1) was generated as described previously (4) . An open reading frame of human MCPIP1 was ligated to the N terminus of EGFP within the vector pEGFP-N1 by using EcoRI and BamHI. In the transient transfection experiment, pEGFP-N1 was used as a control. βWt (containing human β-globin gene) and βWt-TNFα (containing β-globin gene and the potent ARE from tumor necrosis factor α mRNA in the 3'UTR) were kindly provided by Dr. Jens Lykke-Andersen (University of Colorado, Boulder, ref. 12). TNFα-Luc plasmid was a gift from Dr. Dmitry Kuprash (Russian Academy of Science, Russia, ref. 13). iNOS-Luc and PPRE-TK-Luc were from Dr. Mangelsdorf Laboratory (UT Southwestern, Dallas). NF-κB-TK-Luc was purchased from Strategene (La Jolla, CA).
Reagents-The MCPIP1 rabbit polyclonal antibody was prepared against the human recombinant MCPIP1 protein as described previously (4). B7-1 (sc-1632) and actin antibody were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rhodamine-conjugated goat anti-rabbit IgG was from Chemicon International (Temecula, CA). LPS (Escherichia coli 026:B6-derived), human recombinant interferon-γ and actinomycin D were purchased from Sigma (Saint Louis, MI). Doxycycline was from Clontech (Mountain view, CA).
Transfection-For functional study, transient transfection into Raw264.7 cells was performed by electroporation following to the manufacturer's instruction (Amaxa, MD). Briefly, murine macrophage cell line RAW264.7 were grown to confluent in RPMI 1640 medium supplemented with 10%FBS. Cells were collected and washed once with RPMI 1640 medium, and resuspended with the electroporation buffer (Amaxa). After electroporation, the cells were plated on 6-well plate and the transfection efficiency was monitored by fluorescent microscopy. Over 60% cells were GFP positive. Transient transfection into HEK293 cells was performed using lipofectamine 2000 according to the manufacturer's instruction.
For promoter analysis, Raw264.7 cells were seeded into 12-well plate and transfected with Fugene 6 Transfection Reagent (Roche Applied Science) following the manufacturer's instruction. The total amount of plasmid DNA was kept constant within each experiment. Luciferase activity was measured by luciferase Assay System (Promega) and normalized to β-galactosidase activity by cotransfecting the pCMVβgal plasmid in all experiments. All transfections were performed in triplicate and at least repeated two times.
RNA isolation and Northern blot-Total RNA was isolated from cells using RNA STAT-60 reagent (TelTest, Friendswood, TX) followed the manufacturer's instruction. 15 μg of total RNA was denatured and electrophoresed on 1% agarose-formaldehyde gels. The uniformity of sample loading was verified by UV visualization of the ethidium-bromide-stained gel before transfer to Nylon membrane. The cDNA probes for MCPIP1, 2, 3 and 4 were amplified by PCR using individual cDNA clones from ATCC as templates. 32p-labeled cDNA was prepared using the random priming method (Invitrogen). Hybridization was performed using QuckHyb buffer (Strategene) at 65 ºC for 2 hours or overnight. Then the membranes were washed once with 2×SSC and once with 0.1×SSC, 1% SDS for 20 min at 65 ºC.
Quantitative real-time PCR-After removed the genomic DNA using DNAse I (Ambion), 2.4 μg of total RNA from RAW264.7 or BMDM cells was reverse transcribed to cDNA using a commercial available kit (Applied Biosystems). Quantitative realtime PCR was performed with iCycler Thermal Cycler (Bio-Rad, Herculer, CA) using 2×SYBR Green master mix (Bio-Rad). Forty cycles were conducted as follows: 95ºC for 30 s, 60ºC for 30 s, preceded by 1 min at 95ºC for polymerase activation. Primer sequences for all genes we measured in this report are available upon request. Quantification was performed by the dCT method, with β-actin used for normalization.
Protein isolation and Western blot-After washing twice with PBS, cells were gently scraped with a rubber policeman into 5 ml of ice-cold PBS, and centrifuged at 1,000 g for 5 min at 4 °C. Cells from each 10-cm dish were then resuspended and lysed in 0.5 ml of lysis buffer containing 50 mM NaH 2 PO 4 , pH 7.6, 250 mM NaCl, 50 mM NaF, 10 mM imidazole, 0.5% Nonidet P-40, 1 µg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride. The cell lysate was left on ice for about 20 min and then sonicated and centrifuged at 10,000 g for 10 min at 4 °C. Nuclear and cytoplasmic extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Kit (PIERCE, IL) followed the manufacturer's instruction. Protein concentrations were determined by the Bradford method (Bio-Rad Laboratories, Hercules, CA), with bovine serum albumin (BSA) as the standard. For Western blotting, proteins (50 μg) were separated by SDS-PAGE and transferred onto nitrocellulose membranes in transfer buffer containing 0.1% SDS. The membranes were blocked with 5% nonfat dry milk in 0.05% Tween 20 in Tris-buffered saline (TTBS) for 2 h and incubated with the primary antiserum at a 1:1,000 dilution in the blocking buffer for 1 h. After being washed with TTBS three times for 10 min each, the membranes were incubated with a 1:2,000 dilution of secondary antibody in TTBS for 1 h. Following three, 10-min washes with TTBS, membranes were incubated with SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and exposed to X-ray film.
Immunocytochemistry-THP-1 cells were grown on glass coverslips under the conditions described above. After differentiation into macrophages, the cells were treated with or without LPS (1 µg/ml) for 16 h. Then the cells were washed with ice-cold PBS three times before being fixed at room temperature for 10 min in 4% (w/v) paraformaldehyde in PBS. Cells were again washed with PBS twice and permeabilized with 0.2% (v/v) Triton X-100 in TBS at room temperature for 10 min. The cells were then incubated at 4 °C overnight in anti-MCPIP1 serum (1:200 dilution) and 1% normal goat serum in 0.1 M sodium phosphate buffer (pH 7.4). Following two washes with 0.2% (w/v) Triton X-100 in TBS, the cells were incubated at room temperature for 1 h in goat anti-rabbit IgG rhodamine conjugated secondary antibody (1:200 dilution, Chemicon) and 25% normal goat serum in 4 TBS. The cells were rinsed twice with PBS for 10 min each time before being mounted with Vectashield mounting medium (Vector Laboratories, Burlingame, CA). The slides were examined and imaged with Nikon fluorescence microscope (Zeiss, Thornwood, NY).
Determination of TNFα, IL-6 and NO production -NO release was spectrophotometrically determined by measuring the accumulation of nitrite in the medium 8 h after cell activation using Griess Reagent System (Promega). TNFα and IL-6 were measured using ELISA kits (eBioscience, CA).
Ac-LDL uptake-Raw264.7 cells were transfected with pMCPIP1 and pEGFP-N1. 24 hours later the cells were treated with Dil-labeled ac-LDL (Biomedical Technologies Inc.) for time periods as indicated, subsequently washed twice with PBS, and lysed in isopropanol. After sonication followed by 10 minutes centrifugation (13000 g), Dil-labeled ac-LDL content was measured by fluorometry. For microscopy, cells were cultured on glass slides and treated with Dil-labeled ac-LDL.
mRNA stability assay-Two approaches were used to measure the mRNA stability. First, Raw264.7 cells were transfected with pMCPIP1 and pEGFP-N1 respectively. After 8 hours stimulation with LPS (1 μg/ml), transcription was stopped by adding 5 μg/ml actinomycin D. The cells were harvested and RNA was isolated at different time points as indicated. mRNA level was measured by Northern blot. Second, Hela tet-off cells were transfected with βWt or βWt-TNFα reporters and pMCPIP1 or pEGFP-N1 in the presence of 50 ng/ml doxycycline using Fugene 6 transfection reagent (Roche). 24 hours later, a transcription pulse from the reporter mRNA expression plasmid was initiated by washing cells with PBS and feeding with 2 ml DMEM/10% FBS, containing no doxycycline. Six hours later, 3 μg/ml of doxycycline was added to stop transcription. The cells were harvested and RNA was isolated at different time points as indicated. β-globin mRNA level was measured by Northern blot (12).
Short interference RNA-The pre-designed siRNA targeting to mouse MCPIP1 (ID# 170484) as well as its negative control were purchased from Ambion (Austin, TX). The siRNA was transfected into Raw264.7 cells by electroporation using Amaxa Electroporation Unit following the manufacturer's instruction. 24 hours later, the cells were treated with or without LPS (1 μg/ml) for 8 hours. Then the cells were harvested and RNA was isolated to assess for MCPIP1 knockdown and target gene expression.
Statistics-Data were expressed as mean±SD. For comparison between two groups, the unpaired Student's test was used. For multiple comparisons, analysis of variance followed by unpaired Student's test was used. A value of p<0.05 was considered significant.
RESULTS
Identification of MCPIP protein family-MCP-1 not only attracts monocytes from blood stream into vascular wall but also actively regulates gene expression and contributes to the pathogenesis of inflammatory diseases. In an effort to search MCP-1 induced genes in human monocytes using gene microarray analysis, we previously identified a highly MCP-1-induced gene, which was designated as MCPIP (as MCP-1 Induced Protein) (4). This gene encodes a novel CCCH-zinc finger containing protein. By searching the similar sequences in Genbank, we have found that four members belong to this protein family that are designated as MCPIP1, 2, 3 and 4 and encoded by four genes Zc3h12a, Zc3h12b, Zc3h12c and Zc3h12d respectively. The obvious feature of this protein family is that they all contain a single CCCH-type zinc finger (Fig.1A) . In addition to the central CCCH-zinc finger, MCPIP1 also contains two proline-rich domains at N-and Cterminal respectively, which may mediate interaction with SH3 domain containing proteins. MCPIP2 has a RasGEF domain at the C-terminal of the zinc finger motif, suggesting its potential involvement in signal transduction. No other specific motifs are observed in MCPIP3 and 4. It is worthy to note that the zinc finger in MCPIP family is CX5CX5CX3H type and very conserved among this family, which is somewhat different from the two fingers in TTP that were CX8CX5CX3H type (Fig.1B) . The bioinformatics of human and mouse MCPIP family was summarized in Fig.1C . Their mRNA length represents the longest mRNA in GenBank, which may not be the actual full length. The protein weight is predicted and not yet confirmed experimentally. Proteins containing CCCH-zinc finger have been identified from metazoan organisms, yeast, and plant. It seems that MCPIP family is much conserved during evolution as we identified cDNA sequences that encode proteins highly similar to MCPIPs from Drosophila melanogaster, Caenorhabditis elegans to Mus musculus and Rattus norvegicus. The homology between human and mouse MCPIPs varies from 81% to 92%. The amino acid identity between different mouse MCPIP family members is around 40%, but the homology of their zinc finger motif is more than 80%. Phylogenetic analysis indicates that MCPIP2 and MCPIP3 are more closely related to each other than to other MCPIP family members (data not shown).
Induction of MCPIP family during macrophage activation-Macrophage activation is an essential cellular process underlying innate immunity, enabling the body to combat bacteria and other pathogens. In addition to host defense, activated macrophages play a central role in atherogenesis, autoimmunity, and a variety of inflammatory diseases. To explore whether MCPIP family involves in the regulation of macrophage activation, we examined the expression of MCPIPs during LPS-or IFNγ-induced macrophage activation, which are the most studied two inducers for macrophage activation. As shown in Fig.2A , Northern blot revealed that both MCPIP1 and MCPIP3 were highly induced in LPS-but not IFNγ-stimulated murine macrophage cell line Raw264.7. Their expression was raised after 1 hour of LPS treatment, peaked at 2 hour by more than 20 folds above basal line and sustained at a high level for at least 16 hours. MCPIP4 was also induced to some extent by LPS over a 16 hour time course, whereas MCPIP2 was not induced at all during the time periods of both LPS and IFNγ stimulation. LPS also stimulated expression of MCPIP1 in THP-1 derived macrophages over the time course of 1 to 24 h with the similar pattern to Raw264.7 (Fig.2B) . Both MCPIP1 and MCPIP3 were also induced by endogenous cytokines TNFα and IL-1β in THP-1 cells (Fig.2C) . We further explored the effect of LPS on the expression of MCPIPs in mouse primary bone marrow-derived macrophages. In consistence with the results from Raw264.7, both MCPIP1 and MCPIP3 transcripts increased a remarkable 25-fold over its basal levels at 2 h after LPS stimulation and then declined a little bit but sustained a substantial level for 24 h. The basal levels of both MCPIP2 and MCPIP4 seemed very low and did not change after exposure to LPS in the 24 h time period (Fig.2D) . To validate our LPS stimulations, we also assessed the temporal expression of macrophage inflammatory mediators IL-1β, IL-6, MCP-1 and TNFα. Consistent with the previous report, they were all potently induced by tens folds to thousands folds after LPS treatment (Fig.2D ). Interestingly to note that with exception of IL-1β, which constantly increased during the 24 h of stimulation, the mRNA of IL-6, MCP-1 and TNFα reached a peak at 2 or 8 h stimulation and then declined to basal level at 24 h, suggesting that a negative regulatory mechanism may terminate the proinflammatory signals..
Next we examined macrophage MCPIP1 protein expression in response to LPS. Western blot analysis detected a band around 65.5 kd, which is the expected protein size of MCPIP1. MCPIP1 protein was increased by 8 fold within 8 h of LPS stimulation in THP-1 derived macrophages (Fig.2E) . MCPIP1 protein expression was further studied using immunofluorescence microscopy. Treatment of THP-1 macrophages with LPS led to a marked increase in MCPIP1 protein expression. MCPIP1 protein seems predominantly localized in the cytoplasm (Fig.2F) . No specific staining was seen by control serum (Fig.2G ).
MCPIP1
negatively regulates LPS-induced macrophage activation but not affects lipid uptake-MCPIP1 was significantly induced during LPS-induced macrophage activation, suggesting that it may involve in the regulation of this important process. To test this idea, the murine macrophage cell line Raw263.7 cells were transiently transfected with pMCPIP1 or pEGFP-N1 by electroporation. Overexpression of MCPIP1 was confirmed by microscopy as well as Q-PCR and Western blot (Fig.3A) . In cells overexpressing MCPIP1, we observed a marked reduction in the LPS-induced production of TNFα, IL-6 and NO 2 - (Fig.3B ). However, it was noted that overexpression of MCPIP1 did not affect Dil-AcLDL uptake (Fig.3C) .
negatively regulates LPS-induced inflammatory gene expression but not affects the cell surface marker expression in macrophages-Next, we further investigated the effect of MCPIP1 on LPS-stimulated gene expression. As shown in Fig.4A , LPS dramatically induced inflammatory cytokine (TNFα, IL-1β, IL-6 and MCP-1) expression by several folds to thousands folds.
Interestingly, MCPIP1 overexpression significantly blunted the induction of TNFα, IL-1β, IL-6 and MCP-1 by LPS. Conversely, knocking down of MCPIP1 using specific siRNA strongly augmented the induction of TNFα, IL-1β, IL-6 and MCP-1 by LPS (Fig.4A) . The efficient knocking down of MCPIP1 by siRNA was confirmed by Northern blotting (Fig.4C) . We further observed the expression changes of TNFα and MCP-1 during a time period of (Fig.4D) . Interestingly, though two members of costimulatory molecule B7 family B7-1 and B7-2 were also substantially induced by LPS in macrophages, overexpression of MCPIP1 inhibited B7-1 but not B7-2 induction (Fig.4E&F) .
MCPIP1 doesn't affect mRNA degradation of inflammatory cytokines-The expression of inflammatory cytokines including TNFα, IL-1β, IL-6 and MCP-1 is tightly regulated at both transcriptional and posttranscriptional levels. It is noted that TTP family, a well-studied CCCH-zinc finger protein family, can bind to the ARE at 3'UTR of TNFα mRNA and promote its decay. To explore the mechanisms of the MCPIP1 effect on inflammatory cytokines, we first evaluated the potential influence of MCPIP1 on the mRNA stability of TNFα and MCP-1 in LPS-stimulated Raw264.7 cells. In the experiment shown in Fig.5A , the cells were stimulated with LPS (1 μg/ml, Sigma) for 8 h and then treated with actinomycin D (5 μg/ml, Sigma). The RNA was isolated at different time points as indicated. Surprisingly, though both TNFα and MCP-1 mRNA levels were significantly decreased in MCPIP1 overexpressing cells, the half-lives of both TNFα and MCP-1 mRNA were barely affected by overexpression of MCPIP1 (48 min and 110 min vs 44 min and 100 min respectively). These results can't explain why MCPIP1 downregulate the inflammatory cytokine expression. However, there is one possibility that MCPIP1 may work with one or more other inducible proteins to promote mRNA decay and that actinomycin D may block the expression of those proteins to diminish their effect. To exclude this possibility, we performed an ARE-mediated mRNA decay assay in human Hela Tet-off cells as described previously (12) . Basically, two β-globin reporters βWt (containing human β-globin gene) or βWt-TNFα (containing β-globin gene and the potent ARE from TNFα mRNA in the 3'UTR) were cotransfected with pMCPIP1 or pEGFP-N1 into Hela Tet-off cell line (both the reporters and Hela Tet-off cell line were kindly provided by Dr. Jens lykke-Andersen). Transcription of the β-globin mRNA is controlled by a tetracycline regulatory promoter, which allows for measurement of the mRNA decay rate in pulse-chase experiments in human Hela Tet-off cells. The results in Fig.5B showed that MCPIP1 did not affect the ARE-containing β-globin mRNA decay. These results indicate that MCPIP1 does not directly regulate TNFα mRNA stability. MCPIP1 negatively regulates the TNFα and iNOS promoter and blocks LPS-induced NF-κB activation-Then, we asked whether MCPIP1 regulate the promoter activity of the inflammatory genes. For these studies, we used -1.2 kb fragment of the mouse TNFα promoter and -1.5 kb fragment of mouse iNOS promoter. These promoters contain all of regulatory elements necessary for LPS responsiveness in vivo (13, 14) . As shown in Fig.6A , forced expression of MCPIP1 dose-dependently inhibited LPS-induced promoter activity of TNFα and iNOS. As NF-κB is a key transcription factor to regulate both TNFα and iNOS promoter, we tested whether MCPIP1 would also inhibite p65-induced TNFα and iNOS promoter activation. As shown in Fig.6B , MCPIP1 also significantly decreased p65-induced both TNFα and iNOS promoter activity in a dose dependent manner. Finally, we asked whether MCPIP1 can block LPS-induced NF-κB activation. As expected, LPS or p65 markedly induced NF-κB mini promoter activation (Fig.6C) , whereas MCPIP1 strongly blocked LPS or p65 induced NF-κB activation. This effect was specific, since MCPIP1 did not block peroxisome proliferator-activator receptor γ (PPARγ)-induced PPRE promoter activation (Fig.6C) . These results strongly suggest that MCPIP1 may function as a feed-back inhibitor for LPS-induced NF-κB signaling, by which it negatively regulates inflammatory gene expression as well as macrophage activation.
DISCUSSION
In an effort to search MCP-1 induced genes in human monocytes, we previously identified a highly MCP-1-induced protein MCPIP. In this study, we have found that there are four members MCPIP1, 2, 3 and 4 belonging to this subfamily. The obvious feature of this protein family is that they all contain a single CCCH-type zinc finger motif and their transcripts were enriched in immune organ as well as other organs (data not shown). As a start, here we characterized MCPIP1 as a negative regulator of LPS-dependent macrophage activation.
CCCH-type zinc finger is unusual in mammalian genomes. Searching the protein database, we found 58 CCCH-type zinc finger proteins in human and murine genomes (Liang and Fu et al. unpublished data). Most of them were not characterized yet. Among the characterized CCCHtype zinc finger proteins, most of them are capable of binding to RNA and regulate mRNA processing including mRNA maturation, export, modification and turnover (15, 16) . Tristetraprolin (TTP) is the prototype of a family of CCCH zinc finger proteins, which contain two CX8CX5CX3H type zinc finger motifs. Although initially discovered as a gene that could be induced rapidly and transiently by the stimulation of fibroblasts with growth factors and mitogens (17) , it is now known that TTP can bind to AU-rich elements in mRNA, leading to the removal of the poly(A) tail from that mRNA and increased rates of mRNA turnover. TTP-deficient mice developed a systemic inflammatory syndrome with severe polyarticular arthritis and autoimmunity, as well as medullary and extramedullary myeloid hyperplasia due to excess circulating TNFα, resulting from the increased stability of the TNF mRNA and subsequent higher rates of secretion of the cytokine (18) . We originally hypothesized that MCPIP1 may also downregulate the expression of proinflammatory genes through promoting their mRNA decay. Two approaches were used to examine the effect of MCPIP1 on TNFα mRNA decay and show that MCPIP1 does not affect TNFα mRNA stability at all. So MCPIP family may function in a different way to other CCCH-zinc finger families.
We then looked at the impact of MCPIP1 on LPS-induced TNFα promoter activation. Interestingly, forced expression of MCPIP1 significantly inhibited LPS-stimulated TNFα promoter activation. Similar results were also observed in iNOS promoter. These results may explain why overexpression of MCPIP1 dramatically attenuated LPS-induced expression of TNFα and iNOS as well as LPS-induced NO 2 -synthesis and TNFα production in macrophages. The major direct signal pathway for macrophage activation by LPS is the NF-κB signaling pathway (19) . To further understand the molecular mechanisms that MCPIP1 regulates proinflammatory response of macrophages to LPS, we observed the effect of MCPIP1 on LPSdependent NF-κB activation. Overexpression of MCPIP1 inhibited LPS-triggered NF-κB activation, but not rosiglitazone-induced PPARγ activation, suggesting that MCPIP1 may be a novel inhibitor of the NF-κB activation pathways (Fig.6 ). In addition, overexpression of MCPIP1 also inhibited p65-induced activation of TNFα promoter, iNOS promoter and NF-κB mini promoter, suggesting that MCPIP1 may directly target on p65. Interestingly to note, though LPS also significantly induced expression of the macrophage surface protein SR-A and secreted enzyme MMP-9, overexpression of MCPIP1 did not affect their induction at all. Since the major signal pathway contributing to SR-A and MMP-9 induction is p38 kinase-activator ptotein-1 (AP-1) pathway (14, 20) , we reason that MCPIP1 may selectively target on LPS-induced NF-κB signal pathway but not AP-1 signaling. This notion is further supported by the observation of two costimulatory molecules B7-1 and B7-2. B7-1 and B7-2 are related immunoglobulin supergene family members that are expressed by multiple cell types including monocytes, macrophages, B cells, and T cells following activation (21) . Both B7-1 and B7-2 were induced by LPS in macrophages. B7-1 induction is in dependent on NF-κB signaling whereas B7-2 induction is independent NF-κB signaling (22, 23) . We observed that MCPIP1 blocked B7-1 but not B7-2 induction by LPS, suggesting MCPIP1 may function as a specific inhibitor for NF-κB signaling.
Considering that MCPIP1 is induced by a range of inflammatory stimuli such as LPS, TNFα, IL-1β and MCP-1, we conclude that MCPIP1 may function as a feedback inhibitor of macrophage activation by targeting to NF-κB signaling. Currently, the detailed mechanisms whereby MCPIP1 inhibits NF-κB activation are unknown. Several NF-κB inhibitors recently identified such as suppressor of cytokine signaling 1 (SOCS1), A-20, Bcl-3, FLN29 and PDLIM2 downregulate NF-κB signaling by targeting to NF-κB ubiquitination pathway (24) (25) (26) (27) (28) . At least two CCCH-zinc finger containing proteins Roquin and markrin-1 function as ubiquitin ligase (11, 29) . The study to determine whether MCPIP1 also target to NF-κB ubiquitination system is under way.
Currently, the function of the other three members in MCPIP family remains to be determined. MCPIP2 was highly expressed in brain, thymus and testis under normal condition (data not shown), but not expressed in LPS or IFNγ activated macrophages. Beside a central CCCH-zinc finger motif, it has a RasGEF domain, suggesting that it may involve in Ras-mediated signal transduction. MCPIP3 has a different tissue expression pattern with MCPIP1, but it has a similar induction in LPS-induced macrophage activation. MCPIP4 is specifically abundant in spleen, intestine and colon and also induced to some extent by LPS in Raw264.7 cells. Further studies are needed to characterize their function.
It is well established that uncontrolled inflammation does not benefit to organisms, but instead causes tissue impair. Many mechanisms have been evolved to negatively feed-back control the intensity of pathogens-initiated inflammatory response. In this sense, MCPIP protein family may be critically involved in the regulation of macrophage activation and implicated in pathogenesis of inflammatory diseases. Our previous works have demonstrated that MCPIP1 transcript level was much higher in the explanted human hearts with ischemic heart disease (4) and adipose tissues from dietinduced obese mice (unpublished data), both of the conditions being inflammatory status. Future studies will help to elucidate the importance and mechanisms of MCPIP family in human inflammatory diseases. FOOTNOTES * This work was supported by UCF Starting Package (to M.F) and National Institutes of Health Grant HL69458 (to P.E.K).
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The abbreviation used are: MCPIP, MCP-1 induced protein; LPS, lipopolysaccharide; IFNγ, interferon γ; TNFα, tumor necrosis factor α; IL-1β, interleukin 1β; IL-6, interleukin 6; MCP-1, monocyte chemoattractent protein 1; ARE, AU-rich element; PMA, phorbol 12-myristate 13-acetate; BMDM, bone marrow-derived macrophage; FBS, fetal bovine serum; TTP, tristetraprolin. SR-A, scavenger receptor A; SOCS1, suppressor of cytokine signaling 1; iNOS, inducible nitric oxide synthase; AP-1, activator protein 1; NF-κB, nuclear factor κB; PPARγ, peroxisome proliferator-activator receptor γ; GFP, green fluorescent protein. The amino acid sequences of the CCCHtype zinc finger from mouse MCPIP family and TTP were aligned by consensus ClustalW sequence alignment using DNASTAR. The amino acids CCCH have been boxed and the other identical amino acids have been shaded. C: Bioinformatic information of both human and mouse MCPIP family was summarized from NCBI database. The name for each gene was designated in this study. The other name was appeared in the database. Chr. represents Chromosome.
FIGURE 2. Expression of MCPIP family members is induced by LPS in macrophages.
A: Raw264.7 cells were treated with LPS (1 μg/ml) or IFNγ (2 ng/ml) for different times as indicated. Total RNA (15 μg/lane) was analyzed by Northern blotting using 32 P-labeled cDNA probes. EB stained RNA image was served as loading control. B: THP-1 cells were differentiated into macrophages by treatment with PMA (100 ng/ml) for 5 days. After 24 hours of quiescent, the cells were treated with LPS (1 μg/ml) for the indicated times. Total RNA was isolated and Northern blotting was performed to detect MCPIP1 expression. Same membrane was probed with GAPDH and served as loading control. C: THP-1 cells were quiescent for 16 hours and then treated with TNFα (10 ng/ml) or IL-1β (10 ng/ml) for 8 hours. mRNA levels of MCPIP1 and MCPIP3 were measured by RT-PCR and β-actin was served as loading control. D: Monocyte progenitors from C57BL6/J mice were obtained and differentiated into primary macrophages. Primary macrophages were exposed to LPS (1 μg/ml) and harvested at the indicated time points. Samples were processed and subjected quantitative PCR analysis. Data were from three independent experiments and normalized to β-actin expression. E: THP-1 cells were differentiated into macrophages as described above. After 24 hours of quiescent, the cells were treated with LPS (1 μg/ml) for the indicated times. Cell lysates were prepared and MCPIP1 protein level was evaluated by Western blotting (40 μg protein/lane) as described under "Materials and Methods". The intensity of bands was quantified by AlphaImage 2200 (AlphaInnotech, CA) and the normalized protein levels were shown in the figure (bottom). * nonspecific bands. F&G: THP-1 derived macrophages were treated with PBS or 1 μg/ml LPS for 16 hours. The cells were then permeated and stained with antibody to MCPIP1 (B) or control serum (C) and counterstained with 4',6'-diamidino-phenylindole (DAPI). FIGURE 5. Effect of MCPIP1 on TNFα mRNA stability in macrophages. A: Raw264.7 cells were transiently transfected with pEGFP-N1 or pMCPIP1 by electroporation. After 24 hours, the cells were quiescent for 18 hours and then treated with LPS (1 μg/ml) for for 8 hours and then actinomycin D (5 μg/ml) was added to stop transcription. RNA was harvested after different time points as indicated. TNFα and MCP-1 mRNA levels were examined by Northern blot. The intensity of bands was quantified by AlphaImage 2200 (AlphaInnotech, CA). The value of 0 time point was set as 100% and the values of the other points were transformed according to 0 point. The data from three independent experiments were averaged and plotted in the figures at the bottom of each image. B: Hela Tet-off cells were transfected with βWt or βWt-TNFARE reporter with or without pEGFP-N1 or pMCPIP1 as indicated by Fugene 6, in presence of doxycycline. After 24 hours, the cells were washed with PBS and incubated with medium without Doxycycline for 6 hours, and then Doxycycline (3 μg/ml) was added to stop transcription of reporter. RNA was harvested after different time points as indicated. β-globin mRNA level was examined and analyzed by the same procedure as above. FIGURE 6. MCPIP1 negatively regulates the TNFα and iNOS promoter and blocks LPS-induced NF-κB activation. A: Raw264.7 cells were co-transfected a luciferase reporter plasmid under transcriptional control of the TNFα or iNOS promoter with increasing amount of pMCPIP1 (0, 5, 50 and 500 ng/per well). After quiescent for 24 hours, cells were treated with or without LPS (100 ng/ml) as shown and collected for analysis of reporter gene activity 24 hours later. B. Raw264.7 cells were co-transfected the TNFα or iNOS reporter with p65 and increasing amount of pMCPIP1 (0, 5, 50 and 500 ng/per well). C. Raw264.7 cells were co-transfected a NF-κB or PPRE mini reporter with increasing amount of pMCPIP1 (0, 5, 50 and 500 μg/per well). NF-κB reporter was stimulated by LPS (100 ng/ml) or induced by cotransfection with p65, whereas PPRE reporter was stimulated by PPARγ cotranfection and treatment of rosiglitazone (1 μM). Cells were collected for analysis of reporter gene activity 24 hours later. 
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